Found: 57
Select item for more details and to access through your institution.
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6601, doi. 10.1007/s00432-023-04636-y
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors in Esophageal Cancers: Are We Finally Finding the Right Path in the Mist?
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 5, p. 1658, doi. 10.3390/ijms21051658
- By:
- Publication type:
- Article
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis.
- Published in:
- Cancer & Metastasis Reviews, 2012, v. 31, n. 3/4, p. 753, doi. 10.1007/s10555-012-9387-3
- By:
- Publication type:
- Article
Management of Peritoneal Carcinomatosis With Cytoreductive Surgery Combined With Intraperitoneal Chemohyperthermia at a Novel Italian Center.
- Published in:
- In Vivo, 2020, v. 34, n. 4, p. 2061, doi. 10.21873/invivo.12008
- By:
- Publication type:
- Article
Role of Baseline Computed-Tomography-Evaluated Body Composition in Predicting Outcome and Toxicity from First-Line Therapy in Advanced Gastric Cancer Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 5, p. 1079, doi. 10.3390/jcm10051079
- By:
- Publication type:
- Article
Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 7, p. 1562, doi. 10.3390/life13071562
- By:
- Publication type:
- Article
Trans-Arterial Radioembolization for Hepatocellular Carcinoma.
- Published in:
- Digestive Diseases, 2015, v. 33, n. 5, p. 661, doi. 10.1159/000438476
- By:
- Publication type:
- Article
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12225-6
- By:
- Publication type:
- Article
Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Abdominal Visceral-to-Subcutaneous Fat Volume Ratio Predicts Survival and Response to First-Line Palliative Chemotherapy in Patients with Advanced Gastric Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5391, doi. 10.3390/cancers15225391
- By:
- Publication type:
- Article
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 900, doi. 10.3390/cancers15030900
- By:
- Publication type:
- Article
Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the Hurdle.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4896, doi. 10.3390/cancers14194896
- By:
- Publication type:
- Article
Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3738, doi. 10.3390/cancers13153738
- By:
- Publication type:
- Article
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2839, doi. 10.3390/cancers13112839
- By:
- Publication type:
- Article
Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN).
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1304, doi. 10.3390/cancers13061304
- By:
- Publication type:
- Article
TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2049, doi. 10.3390/cancers12082049
- By:
- Publication type:
- Article
Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 939, doi. 10.3390/cancers11070939
- By:
- Publication type:
- Article
Network meta‐analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence.
- Published in:
- Liver International, 2024, v. 44, n. 10, p. 2763, doi. 10.1111/liv.16047
- By:
- Publication type:
- Article
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data.
- Published in:
- Liver International, 2023, v. 43, n. 8, p. 1803, doi. 10.1111/liv.15641
- By:
- Publication type:
- Article
The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer.
- Published in:
- Liver International, 2020, v. 40, n. 3, p. 704, doi. 10.1111/liv.14314
- By:
- Publication type:
- Article
Platinum sensitivity in patients with IDH1/2 mutated vs wild‐type intrahepatic cholangiocarcinoma: A propensity score‐based study.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 8, p. 1310, doi. 10.1002/ijc.34182
- By:
- Publication type:
- Article
EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2014, v. 33, n. 1, p. 1, doi. 10.1186/s13046-014-0077-6
- By:
- Publication type:
- Article
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0232449
- By:
- Publication type:
- Article
Results of the observational prospective RealFLOT study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comment on: 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Neuroendocrine Liver Metastases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 559, doi. 10.1007/s00280-009-1196-1
- By:
- Publication type:
- Article
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 965, doi. 10.1007/s00280-008-0840-5
- By:
- Publication type:
- Article
First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 4, p. 938, doi. 10.1002/ijc.30125
- By:
- Publication type:
- Article
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 6, p. 958, doi. 10.1007/s10120-023-01411-3
- By:
- Publication type:
- Article
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 197, doi. 10.1007/s10120-021-01227-z
- By:
- Publication type:
- Article
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 6, p. 1064, doi. 10.1007/s10120-020-01078-0
- By:
- Publication type:
- Article
Sarcopenia in gastric cancer: when the loss costs too much.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 4, p. 563, doi. 10.1007/s10120-017-0722-9
- By:
- Publication type:
- Article
A Tailoring of the Unified Architecture Framework's Meta‐Model for the Modeling of Systems‐of‐Systems.
- Published in:
- Incose International Symposium, 2018, v. 28, n. 1, p. 1691, doi. 10.1002/j.2334-5837.2018.00577.x
- By:
- Publication type:
- Article
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database.
- Published in:
- International Journal of Biological Markers, 2015, v. 30, n. 1, p. e65, doi. 10.5301/jbm.5000117
- By:
- Publication type:
- Article
Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 6, p. 1046, doi. 10.3390/diagnostics11061046
- By:
- Publication type:
- Article
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 10, p. 1317, doi. 10.1080/0284186X.2021.1953704
- By:
- Publication type:
- Article
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum].
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 5123, doi. 10.2147/CMAR.S215110
- By:
- Publication type:
- Article
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology.
- Published in:
- Oncology, 2024, v. 102, n. 2, p. 157, doi. 10.1159/000533406
- By:
- Publication type:
- Article
Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy.
- Published in:
- Oncology, 2023, v. 101, n. 7, p. 435, doi. 10.1159/000530853
- By:
- Publication type:
- Article
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients.
- Published in:
- Oncology, 2021, v. 99, n. 5, p. 292, doi. 10.1159/000512796
- By:
- Publication type:
- Article
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.
- Published in:
- Oncology, 2018, v. 95, n. 6, p. 344, doi. 10.1159/000491753
- By:
- Publication type:
- Article
Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients.
- Published in:
- Oncology, 2016, v. 91, n. 6, p. 311, doi. 10.1159/000443962
- By:
- Publication type:
- Article
Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients.
- Published in:
- Oncology, 2016, v. 91, n. 5, p. 283, doi. 10.1159/000448004
- By:
- Publication type:
- Article